Post-effective Amendment to an S-8 Filing (s-8 Pos)
July 19 2018 - 4:13PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on July 19, 2018
Registration No. 333-146479
Registration No. 333-193136
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
Post-Effective Amendment No. 1 to Form S-8
Registration Statement No. 333-146479
Post-Effective Amendment No. 1 to Form S-8
Registration Statement No. 333-193136
IDEXX
Laboratories, Inc.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
|
|
01-0393723
|
(State or other jurisdiction
of incorporation or
organization)
|
|
|
|
(IRS Employer
Identification No.)
|
One IDEXX Drive
Westbrook, Maine
|
|
|
|
04092
|
(Address of Principal
Executive Offices)
|
|
|
|
(Zip Code)
|
2009 Stock Incentive Plan
2018 Stock Incentive Plan
(Full title of the plan)
Jacqueline L. Studer
Corporate Vice President, General Counsel
and Secretary
IDEXX Laboratories, Inc.
One IDEXX Drive
Westbrook, Maine 04092
(Name and address of agent for service)
(207) 556-0300
(Telephone number, including area code, of agent
for service)
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
x
|
Accelerated filer
¨
|
|
|
Non-accelerated
filer
¨
(Do not check if a smaller reporting company)
|
Smaller
reporting company
¨
Emerging
growth company
¨
|
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
EXPLANATORY NOTE
On May 9, 2018, the shareholders of IDEXX Laboratories,
Inc. (“IDEXX” or the "Registrant") approved the 2018 Stock Incentive Plan (the “2018 Plan”).
Effective upon the approval of the 2018 Plan, (i) no additional awards are to be granted pursuant to the terms of the 2009 Stock
Incentive Plan (the “Prior Plan”), (ii) awards outstanding under the Prior Plan as of May 9, 2018, representing 3,264,033
shares, shall remain in full force and effect under the Prior Plan according to their respective terms (the “Outstanding
Awards”), (iii) 7,500,000 shares were reserved for grants of awards under the 2018 Plan, subject to adjustment in the case
of certain corporate events under the terms of the 2018 Plan and (iv) to the extent that an award granted under the Prior Plan
or the 2018 Plan is forfeited, terminates, expires or lapses without being exercised (to the extent applicable), or is settled
for cash, the shares subject to such award not delivered as a result thereof, including any shares that are unearned under performance
awards taking into account the maximum possible payout (the “Returned Shares”), shall again be available for awards
under the 2018 Plan.
IDEXX has previously registered shares of common
stock to be issued under the Prior Plan on Registration Statement No. 333-146479, filed on June 19, 2009 and on Registration Statement
No. 333-193136, filed on December 30, 2013 (collectively, the "Registration Statements"). Pursuant to the undertaking
in Item 512(a)(1)(iii) of Regulation S-K that the Registrant disclose a material change in the plan of distribution as it was originally
disclosed in the Registration Statements and SEC Compliance and Disclosure Interpretation 126.43, the Registrant is filing this
Post-Effective Amendment to the Registration Statements to reflect that, effective as of May 9, 2018, the Prior Plan will no longer
be utilized for new issuances of shares (other than in connection with the Outstanding Awards) nor for the issuance of any Returned
Shares but, with respect to those shares previously registered on the Registration Statements that remain unissued and not subject
to an Outstanding Award as of May 9, 2018, 7,500,000 of such shares have been authorized and may be issued pursuant to the 2018
Plan and the Returned Shares, if any, have been authorized and may also be issued under the 2018 Plan. In addition, this Post-Effective
Amendment to the Registration Statements includes as an exhibit hereto a copy of the 2018 Plan and a new opinion as to the validity
of the shares of common stock that were previously issuable pursuant to the Prior Plan, which are available for issuance under
the 2018 Plan going forward. All other items of the Registration Statements are incorporated herein by reference without change.
No additional securities are being registered
by this Post-Effective Amendment to the Registration Statements.
PART II. INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents
by Reference.
The Registrant is subject
to the informational and reporting requirements of Sections 13(a), 14, and 15(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and in accordance therewith files reports, proxy statements and other information with
the Securities and Exchange Commission (the “Commission”). The following documents, filed with the Commission, are
incorporated in this Registration Statement by reference:
(1) The
Registrant’s latest annual report filed pursuant to Section 13(a) or Section 15(d) of the Exchange Act or the latest prospectus
filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”), that contains audited
financial statements for the Registrant’s latest fiscal year for which such statements have been filed;
(2) All
other reports filed pursuant to Section 13(a) or Section 15(d) of the Exchange Act since the end of the fiscal year covered by
the document referred to in (1) above; and
(3) The
description of the common stock, $.10 par value per share, of the Registrant (the “Common Stock”) contained in a registration
statement filed on Form 8-A under the Exchange Act, including any amendment or report filed for the purpose of updating such description.
All
documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior
to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters
all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date
of filing of such documents;
provided,
however
that documents or information deemed to have been furnished
and not filed in accordance with Commission rules shall not be deemed incorporated by reference into this Registration Statement.
Any statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference
herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified
or amended, to constitute a part of this Registration Statement.
|
Item 5.
|
Interests of Named Experts and Counsel.
|
Not applicable.
|
Item 6.
|
Indemnification of Directors and Officers.
|
Section 145 of
the General Corporation Law of the State of Delaware (the “DGCL”), as amended, gives Delaware corporations the power
to indemnify each of their present and former directors or officers under certain circumstances, if such person acted in good faith
and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation.
Article Ninth
of the Registrant’s Certificate of Incorporation provides that no director of the Registrant shall be liable for any breach
of fiduciary duty, except to the extent that the DGCL prohibits the limitation of liability of directors for breach of fiduciary
duty.
Article Thirteenth
of the Registrant’s Certificate of Incorporation provides that a director or officer of the Registrant (a) shall be
indemnified by the Registrant against all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement
incurred in connection with any litigation or other legal proceeding (other than an action by or in the right of the Registrant)
brought against him by virtue of his position as a director or officer of the Registrant if he acted in good faith and in a manner
he reasonably believed to be in, or not opposed to, the best interests of the Registrant and with respect to any criminal action
or proceeding, if he had no reasonable cause to believe his conduct was unlawful and (b) shall be indemnified by the Registrant
against all expenses (including attorneys’ fees) and amounts paid in settlement incurred in connection with any action by
or in the right of the Registrant brought against him by virtue of his position as a director or officer of the Registrant if he
acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the Registrant, except
that no indemnification shall be made with respect to any matter as to which such person shall have been adjudged to be liable
to the Registrant, unless a court determines that, despite such adjudication but in view of all of the circumstances, he is entitled
to indemnification of such expenses. Notwithstanding the foregoing, to the extent that a director or officer has been successful,
on the merits or otherwise, including, without limitation, the dismissal of an action without prejudice, he is required to be indemnified
by the Registrant against all expenses (including attorneys’ fees) incurred in connection therewith. Expenses shall be advanced
to a director or officer at his request, provided that he undertakes to repay the amount advanced if it is ultimately determined
that he is not entitled to indemnification for such expenses.
Indemnification is
required to be made unless the Registrant determines that the applicable standard of conduct required for indemnification has not
been met. In the event of a determination by the Registrant that the director or officer did not meet the applicable standard of
conduct required for indemnification, or if the Registrant fails to make an indemnification payment within 60 days after such
payment is claimed by such person, such person is permitted to petition the court to make an independent determination as to whether
such person is entitled to indemnification. As a condition precedent to the right of indemnification, the director or officer must
give the Registrant notice of the action for which indemnity is sought, and the Registrant has the right to participate in such
action or assume the defense thereof.
Article Thirteenth
of the Registrant’s Certificate of Incorporation further provides that the indemnification provided therein is not exclusive
and provides that in the event that the DGCL is amended to expand the indemnification permitted to directors or officers, the Registrant
must indemnify those persons to the fullest extent permitted by such law as so amended.
As permitted by Section 145(g) of the DGCL,
under Article Thirteenth of the Registrant’s Certificate of Incorporation, the Registrant may purchase insurance on behalf
of its directors and officers against any expense, liability or loss incurred by him or her in any such capacity, or arising out
of such person’s status as such, whether or not the Registrant would have the power to indemnify such person against such
expense, liability or loss under the DGCL. The Registrant maintains such insurance.
Under
the Prior Plan, no director or person acting pursuant to the authority delegated by the Board shall be liable for any action or
determination relating to or under the Plan made in good faith.
Under the 2018 Plan, no director or person acting pursuant
to the authority delegated by the Registrant’s board shall be liable for any action or determination relating to or under
the Plan made in good faith. In addition to such other rights of indemnification as they may have as Directors or members of a
Committee, and to the extent allowed by applicable laws, the Board and Committee shall be indemnified by the Company against the
reasonable expenses, including attorney’s fees, actually incurred in connection with any action, suit or proceeding or in
connection with any appeal therein, to which the Board or Committee may be party by reason of any action taken or failure to act
under or in connection with the 2018 Plan or any Award granted under the 2018 Plan, and against all amounts paid in settlement
thereof (
provided
,
however
, that the settlement has been approved by the Company, which approval
shall not be unreasonably withheld) or paid in satisfaction of a judgment in any such action, suit or proceeding, except in relation
to matters as to which it shall be adjudged in such action, suit or proceeding that the Board or Committee did not act in good
faith and in a manner which such person reasonably believed to be in the best interests of the Company, or in the case of a criminal
proceeding, had no reason to believe that the conduct complained of was unlawful;
provided
,
however
,
that within 60 days after the institution of any such action, suit or proceeding, such Board or Committee member shall, in writing,
offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding.
|
Item 7.
|
Exemption from Registration Claimed.
|
Not applicable.
The Exhibit Index immediately
preceding the exhibits is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Prior Plan Registration Statements to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of Westbrook, State of Maine, on this 19th day of July
2018.
|
|
IDEXX Laboratories, Inc.
|
|
|
|
|
By:
|
/s/ Jonathan W. Ayers
|
|
|
|
|
|
Jonathan W. Ayers
Chairman, President and
Chief Executive Officer
|
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of
IDEXX Laboratories, Inc., hereby severally constitute and appoint Jonathan W. Ayers and Brian P. McKeon, and each of them singly,
our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities
indicated below, any amendments and post-effective amendments to this registration statement filed herewith and generally to do
all such things in our names and on our behalf in our capacities as officers and directors to enable IDEXX Laboratories, Inc. to
comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission,
hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration
statement and any and all amendments thereto.
Pursuant to the requirements of the Securities
Act of 1933, as amended, this Post-Effective Amendment to the Registration Statements has been signed by the following persons
in the capacities and on the dates indicated.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
Jonathan W. Ayers
|
|
Chairman of the Board, Chief
Executive Officer and President
|
|
|
Jonathan W. Ayers
|
|
(Principal Executive Officer)
|
|
July 19, 2018
|
|
|
|
|
|
/s/
Brian P. McKeon
|
|
Executive Vice President, Chief
Financial Officer and Treasurer
|
|
|
Brian P. McKeon
|
|
(Principal Financial and Accounting Officer)
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Bruce
L. Claflin
|
|
|
|
|
Bruce L. Claflin
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Stuart
M. Essig, PhD
|
|
|
|
|
Stuart M. Essig, PhD
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Rebecca
M. Henderson, PhD
|
|
|
|
|
Rebecca M. Henderson, PhD
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Daniel
M. Junius
|
|
|
|
|
Daniel M. Junius
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Lawrence
D. Kingsley
|
|
|
|
|
Lawrence D. Kingsley
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ M.
Anne Szostak
|
|
|
|
|
M. Anne Szostak
|
|
Director
|
|
July 19, 2018
|
|
|
|
|
|
/s/ Sophie
V. Vandebroek, PhD
|
|
|
|
|
Sophie V. Vandebroek, PhD
|
|
Director
|
|
July 19, 2018
|
INDEX TO EXHIBITS
|
(1)
|
Previously filed with the Securities and Exchange Commission as Exhibit No. 3(i) to Quarterly
Report on Form 10-Q for the quarter ended June 30, 2006, File No. 0-19271, and incorporated herein by reference.
|
|
(2)
|
Previously filed with the Securities and Exchange Commission as Exhibit No. 3.1 to the Current Report on Form 8-K filed December
12, 2017, File No. 0-19271.
|
(3) Previously filed with the Securities
and Exchange Commission as Exhibit 99.1 to the Registration Statement on Form S-8 filed December 30, 2013, File No. 333-193136.
|
(4)
|
Previously filed with the Securities and Exchange Commission as Appendix B to the Registrant’s Definitive Proxy Statement
on Schedule 14A, File No. 0-19271, filed March 29, 2018 and incorporated herein by reference.
|
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Mar 2024 to Apr 2024
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Apr 2023 to Apr 2024